We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canada’s 1.5 Million AstraZeneca Doses From Troubled Emergent Plant Safe and High Quality, Regulator Says
Canada’s 1.5 Million AstraZeneca Doses From Troubled Emergent Plant Safe and High Quality, Regulator Says
As work continues on remedying a host of concerning issues at Emergent BioSolutions’ Bayview, Md., facility, Health Canada has reported that the 1.5 million AstraZeneca (AZ) doses it received from the site were up to par for safety and quality.